WARNING: THE EDGAR SYSTEM ENCOUNTERED ERROR(S) WHILE PROCESSING THIS SCHEDULE. <ARTICLE> 5 <LEGEND> This schedule contains summary financial information extracted from the Condensed Consolidated Financial Statements of BioMarine Technologies, Inc. and is qualified inits entirety by reference to such financial statements. </LEGEND> <PERIOD-TYPE> YEAR <FISCAL-YEAR-END> DEC-31 <PERIOD START> JAN-01-1999 <PERIOD-END> DEC-31-1999 <CASH> 1982 <SECURITIES> 0 <RECEIVABLES> 0 <ALLOWANCES> 0 <INVENTORY> 0 <CURRENT-ASSETS> 80,203 <PP&E> 62,077 <DEPRECIATION> 100,593 <TOTAL-ASSETS> 80,203 <CURRENT-LIABILITIES> 531,037 <BONDS> 0 <PREFERRED-MANDATORY> 0 <PREFERRED> 2,941 <COMMON> 20,300 <OTHER-SE> (474,035) <TOTAL-LIABILITY-AND-EQUITY> 80,243 <SALES> 0 <TOTAL-REVENUES> 133,920 <CGS> 0 <TOTAL-COSTS> 0 <OTHER-EXPENSES> 324,017 <LOSS-PROVISION> 0 <INTEREST-EXPENSE> 29,000 <INCOME-PRETAX> (190,097) <INCOME-TAX> 0 <INCOME-CONTINUING> (190,097) <DISCONTINUED> 0 <EXTRAORDINARY> 0 <CHANGES> 0 <NET-INCOME> (190,097) <EPS-BASIC> (0.09) <EPS-DILUTED> (0.09)